Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress

Autor: Craig S Anderson, Anthony Rodgers, H Asita de Silva, Sheila Ouriques Martins, Catharina JM Klijn, Bimsara Senanayake, Ruth Freed, Laurent Billot, Hisatomi Arima, Nguyen Huy Thang, Wan Asyraf Wan Zaidi, Tinatin Kherkheulidze, Kolawole Wahab, Urs Fisher, Tsong-Hai Lee, Christopher Chen, Octavio Pontes-Neto, Thompson Robinson, Jiguang Wang, Sharon Naismith, Lili Song, Floris H Schreuder, Richard I Lindley, Mark Woodward, Stephen MacMahon, Rustam Al-Shahi Salman, Clara K Chow, John Chalmers

Publikováno v: International Journal of Stroke, 17, 10, pp. 1156-1162
International Journal of Stroke, 17, 1156-1162
Anderson, C S, Rodgers, A, De Silva, H A, Martins, S O, Klijn, C J, Senanayake, B, Freed, R, Billot, L, Arima, H, Thang, N H, Zaidi, W A W, Kherkheulidze, T, Wahab, K, Fisher, U, Lee, T, Chen, C, Pontes-neto, O, Robinson, T, Wang, J, Naismith, S, Song, L, Schreuder, F H, Lindley, R I, Woodward, M, Macmahon, S, Salman, R A, Chow, C K & Chalmers, J 2022, ' Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress ', International Journal of Stroke, pp. 174749302110686 . https://doi.org/10.1177/17474930211068671

Background: Patients who suffer intracerebral hemorrhage (ICH) are at very high risk of recurrent ICH and other serious cardiovascular events. A single-pill combination (SPC) of blood pressure (BP) lowering drugs offers a potentially powerful but sim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590b06a3ddf9c9e0f53e5ddf679a6980